Metropolis Healthcare Limited

BSE: 542650 NSE: METROPOLIS
Metropolis Healthcare Limited - healthcare in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN L73100MH2000PLC192798 Incorporated 10 November 2000 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Listed - NSE: METROPOLIS · BSE: 542650 Public Limited Company healthcare
Data last updated
Revenue · FY 2026
₹1,645.85 Cr
▲ 23.64% YoY
EBITDA · FY 2026
₹426.43 Cr
▲ 34.05% YoY
Net profit · FY 2026
₹191.18 Cr
▲ 31.38% YoY
Authorised capital
₹63.86 Cr
Registered with MCA
Paid-up capital
₹10.36 Cr
Issued & subscribed
Open charges
₹60.19 Cr
Satisfied ₹416.05 Cr
Company age
26 yrs
Est. 2000
Employees · EPFO
4,503
Latest available

About Metropolis Healthcare Limited

Data last updated: 22 December 2025

Metropolis Healthcare Limited is a public limited company based in Mumbai, Maharashtra, India. It specialises in diagnostic centers and pathology labs, a part of the broader healthcare sector. Incorporated on 10 November 2000, the company has been in operation for over 26 years.

Registered with ROC Mumbai under CIN L73100MH2000PLC192798. Listed on BSE: 542650 and NSE: METROPOLIS.

Capital: an authorised share capital of ₹63.86 Cr and a paid-up capital of ₹10.36 Cr. Formerly known as Articles of Association of Metropolis Healthcare Limited and Pathnet India Limited. It is led by directors including Subramanian Ranganathan and Sanjay Bhatnagar.

Last AGM: 13 August 2025. Financial statements filed for year ended 31 March 2025. Office: Mumbai, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹1,346.32 Cr, a growth of 11% compared to the previous year.

The company has a workforce of approximately 4,503 employees as per the latest available data. Its group structure includes 4 subsidiaries.

The company is associated with 3 brands - Too Shy To Ask, Hitech, Metropolis India. As per MCA filings, the company has open charges of ₹60.19 Cr and satisfied charges of ₹416.05 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website metropolisindia.com.

Company Details of Metropolis Healthcare Limited
CIN L73100MH2000PLC192798
Registration Number 192798
Incorporation Date 10 November 2000
ROC Mumbai
Listing Status Listed (BSE: 542650, NSE: METROPOLIS)
Company Status Active
Date of Last AGM 13 August 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Chemmenkotil Surendran Managing Director Ameera Sushil Shah Whole-Time Director Sameer Prakash Patel Cfo
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    metropolisindia.com
  • Social Media
  • Apps
  • Registered Address
    4Th Floor East Wing Plot – 254 B, Nirlon House Dr. Annie Besant Road Worli, Mumbai, Maharashtra, India – 400030
  • Industry
    Healthcare, Diagnostic Centers & Pathology Labs
Company report
Metropolis Healthcare Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Metropolis Healthcare Limited report

Financials, compliance, directors, charges, ownership and filings for Metropolis Healthcare Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Metropolis Healthcare Limited

Metropolis Healthcare Limited has undergone 4 name changes throughout its history. The current legal name is Metropolis Healthcare Limited, reflecting the company's evolution and rebranding over time.

Company Name Status
Metropolis Healthcare Limited Current
Articles Of Association Of Metropolis Healthcare Limited Previous
Pathnet India Limited Previous
Pathnet India Private Limited Previous
Pathnet India Limited Previous

CIN History of Metropolis Healthcare Limited

Metropolis Healthcare Limited has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L73100MH2000PLC192798, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L73100MH2000PLC192798 Current
U73100MH2000PLC192798 Previous
U73100MH2000PTC192798 Previous
U73100DL2000PTC108483 Previous

Associated Brands with Metropolis Healthcare Limited

Metropolis Healthcare Limited operates multiple associated brands including Too Shy To Ask, HITECH, and Metropolis India. These brands represent Metropolis Healthcare Limited's diversified market presence and brand portfolio.

Brand Description Website
Too Shy To Ask
Provides online education on sexual health, mental health, and personal safety for teens and parents. tooshytoask.org
HITECH
Chain of diversified clinical laboratory centers hitechlabsindia.in
Metropolis India
Diagnostic centers are operated as a nationwide chain. metropolisindia.com

Competitors & Alternatives of Metropolis Healthcare Limited

Brands and companies operating in the same space as Metropolis Healthcare Limited include Thyrocare, Dr Lal PathLabs, Redcliffe Labs and 7 more.

Competitor Description Location Founded
Thyrocare Thyrocare Diagnostic testing centers for pathology and health screenings are operated. Mumbai, India, India 1996
Dr Lal PathLabs Dr Lal PathLabs Chain of pathology and radiology labs Gurugram, India, India 1949
Redcliffe Labs Redcliffe Labs Home-based diagnostic tests are booked via an online platform. Noida, India, India 2018
Orange health Orange health At-home diagnostic tests are booked and collected by phlebotomists. Bengaluru, India, India 2020
Krsnaa Diagnostics Krsnaa Diagnostics Chain of radiology & pathology laboratory centers Pune, India, India 2011
Suraksha Diagnostics Suraksha Diagnostics Pathology, molecular diagnostics, and imaging services are provided. Kolkata, India, India 2005
Agilus Diagnostics Agilus Diagnostics Leading diagnostic chain providing quality blood test and full body checkup services Gurugram, India, India 1995
Vijaya Diagnostic Centre Vijaya Diagnostic Centre Diagnostic services are offered via a chain of centers. Hyderabad, India, India 1981
Grace.health Grace.health App for tracking women's health Stockholm, Sweden, Sweden 2017
Igenetic Igenetic Provider molecular diagnostic solutions and services Mumbai, India, India 2013

Business Activity of Metropolis Healthcare Limited

Metropolis Healthcare Limited is engaged in the principal business activity of hospital and medical care, with detailed activities including medical and dental practice, nursing, pathology, blood bank services, etc..

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
Q Hospital and Medical Care Q2 Medical and dental practice, Nursing, pathology, blood bank services, etc. *********

Auditor Details of Metropolis Healthcare Limited

Metropolis Healthcare Limited is audited by B S R & Co. LLP (ICAI peer reviewed, certificate valid till 2028-07-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
B S R & Co. LLP (ICAI peer reviewed, certificate valid till 2028-07-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Metropolis Healthcare Limited

Metropolis Healthcare Limited is currently managed by 13 directors, with 35 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Subramanian Ranganathan
Also directs: Capri Global Capital Limited, Metropolis Healthcare Limited, Proventus Agrocom Limited and 5 more
Director 21 Aug 2023 2 Years 10 Months Current
Sanjay Bhatnagar
Also directs: Metropolis Healthcare Limited, Eih Limited, Bhatnagar Estates Private Limited
Director 07 Sep 2018 7 Years 10 Months Current
Ameera Sushil Shah
Also directs: Metropolis Healthcare Limited, Metz Advisory Llp, G&L Advisory Llp and 5 more
Whole-Time Director 06 May 2008 18 Years 2 Months Current
Aparna Chetan Rajadhyaksha
Also directs: Metropolis Healthcare Limited
Director 22 May 2024 2 Years 1 Months Current
Sushil Kanubhai Shah
Also directs: Metropolis Healthcare Limited, Nitrolabs Technology Private Limited
Director 17 Aug 2005 20 Years 10 Months Current
Hemant Sachdev
Also directs: Metropolis Healthcare Limited, G&L Advisory Llp, Nexus Nextgen Works Llp and 5 more
Director 27 May 2021 5 Years 1 Months Current
Showing 6 of 13 current directors. View all directors

Financials of Metropolis Healthcare Limited FY 2026 filings available

Metropolis Healthcare Limited reported revenue of ₹1,645.85 Cr (up 23.64% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue · FY 2026
₹1,645.85 Cr ▲ 23.64%
Profit · FY 2026
₹191.18 Cr ▲ 31.38%
EBITDA · FY 2026
₹426.43 Cr ▲ 34.05%
Revenue₹ Cr · Consolidated01,0002,000FY 2020: ₹856 Cr856FY 2020FY 2021: ₹998 Cr · +16.5% YoY998+16.5%FY 2021FY 2022: ₹1,228 Cr · +23.1% YoY1,228+23.1%FY 2022FY 2023: ₹1,148 Cr · -6.5% YoY1,148-6.5%FY 2023FY 2024: ₹1,208 Cr · +5.2% YoY1,208+5.2%FY 2024FY 2025: ₹1,331 Cr · +10.2% YoY1,331+10.2%FY 2025FY 2026: ₹1,646 Cr · +23.6% YoY1,646+23.6%FY 2026
Net Profit₹ Cr · Consolidated0100200300FY 2020: ₹128 Cr128FY 2020FY 2021: ₹183 Cr · +43.7% YoY183+43.7%FY 2021FY 2022: ₹215 Cr · +17.1% YoY215+17.1%FY 2022FY 2023: ₹143 Cr · -33.2% YoY143-33.2%FY 2023FY 2024: ₹128 Cr · -10.4% YoY128-10.4%FY 2024FY 2025: ₹146 Cr · +13.3% YoY146+13.3%FY 2025FY 2026: ₹191 Cr · +31.4% YoY191+31.4%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year0200400600Q1'25: ₹313 Cr · +13.1% YoY313+13.1%Q1'25Q2'25: ₹350 Cr · +13.4% YoY350+13.4%Q2'25Q3'25: ₹323 Cr · +10.9% YoY323+10.9%Q3'25Q4'25: ₹345 Cr · +4.3% YoY345+4.3%Q4'25Q1'26: ₹386 Cr · +23.2% YoY386+23.2%Q1'26Q2'26: ₹429 Cr · +22.7% YoY429+22.7%Q2'26Q3'26: ₹406 Cr · +25.8% YoY406+25.8%Q3'26Q4'26: ₹425 Cr · +23% YoY425+23%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹1,645.85 Cr ₹1,331.2 Cr ₹1,207.71 Cr ₹1,148.21 Cr ₹1,228.34 Cr ₹997.99 Cr ₹856.41 Cr
Other Income ₹25.58 Cr ₹15.11 Cr ₹9.12 Cr ₹15.22 Cr ₹17.62 Cr ₹12.05 Cr ₹8.57 Cr
Total Income ₹1,671.43 Cr ₹1,346.32 Cr ₹1,216.83 Cr ₹1,163.43 Cr ₹1,245.96 Cr ₹1,010.03 Cr ₹864.97 Cr
Cost of Materials Consumed ₹324.52 Cr ₹268.68 Cr ₹242.57 Cr ₹253.26 Cr ₹276.02 Cr ₹252.16 Cr ₹204.14 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Employee Benefit Expense ₹377.36 Cr ₹313.75 Cr ₹275.78 Cr ₹252.73 Cr ₹233.17 Cr ₹198.64 Cr ₹190.16 Cr
Finance Costs ₹24.54 Cr ₹18.57 Cr ₹22.54 Cr ₹26.8 Cr ₹19.74 Cr ₹7.78 Cr ₹8.34 Cr
Depreciation & Amortisation ₹133.72 Cr ₹108.68 Cr ₹94.47 Cr ₹89.22 Cr ₹63.22 Cr ₹45.94 Cr ₹39.27 Cr
Other Expenses ₹543.12 Cr ₹445.77 Cr ₹406.78 Cr ₹353.92 Cr ₹376.35 Cr ₹261.18 Cr ₹229.29 Cr
Total Expenses ₹1,403.27 Cr ₹1,155.46 Cr ₹1,042.14 Cr ₹975.93 Cr ₹968.51 Cr ₹765.71 Cr ₹671.19 Cr
Profit Before Exceptional Items & Tax ₹268.17 Cr ₹190.85 Cr ₹174.69 Cr ₹187.5 Cr ₹277.45 Cr ₹244.32 Cr ₹193.78 Cr
Exceptional Items -₹8.99 Cr ₹0 ₹0 ₹0 ₹15.9 Cr ₹0 -₹24.53 Cr
Profit Before Tax ₹259.18 Cr ₹190.85 Cr ₹174.69 Cr ₹187.5 Cr ₹293.35 Cr ₹244.32 Cr ₹169.25 Cr
Total Tax Expense ₹67.99 Cr ₹45.34 Cr ₹46.23 Cr ₹44.11 Cr ₹78.67 Cr ₹60.97 Cr ₹41.18 Cr
Net Profit ₹191.18 Cr ₹145.51 Cr ₹128.46 Cr ₹143.39 Cr ₹214.69 Cr ₹183.35 Cr ₹127.55 Cr
  attributable to Owners ₹190.02 Cr ₹144.97 Cr ₹127.82 Cr ₹142.88 Cr ₹214.18 Cr ₹183.1 Cr ₹127.33 Cr
  attributable to NCI ₹1.16 Cr ₹54.56 Lakh ₹63.94 Lakh ₹51.14 Lakh ₹50.4 Lakh ₹25.36 Lakh ₹22.66 Lakh
Other Comprehensive Income ₹4.82 Cr -₹31.25 Lakh -₹82.32 Lakh -₹34.84 Lakh -₹2.32 Cr -₹1.08 Cr -₹3 Cr
Total Comprehensive Income ₹196 Cr ₹145.2 Cr ₹127.63 Cr ₹143.05 Cr ₹212.37 Cr ₹182.27 Cr ₹124.55 Cr
EBITDA (computed) ₹426.43 Cr ₹318.11 Cr ₹291.69 Cr ₹303.52 Cr ₹360.41 Cr ₹298.05 Cr ₹241.39 Cr
Basic EPS ₹9.19 ₹28.29 ₹24.95 ₹27.91 ₹41.87 ₹35.97 ₹25.36
Diluted EPS ₹9.19 ₹28.15 ₹24.87 ₹27.81 ₹41.66 ₹35.79 ₹25.25
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹2,138.05 Cr ₹1,867.34 Cr ₹1,555.06 Cr ₹1,501.61 Cr
Non-current Assets ₹1,669.44 Cr ₹1,521.4 Cr ₹1,239.23 Cr ₹1,198.87 Cr
Current Assets ₹468.61 Cr ₹345.94 Cr ₹315.83 Cr ₹302.73 Cr
Property, Plant & Equipment ₹215.3 Cr ₹190.26 Cr ₹155.89 Cr ₹137.25 Cr
Inventories ₹45.49 Cr ₹47.84 Cr ₹38.69 Cr ₹44.59 Cr
Trade Receivables ₹170.29 Cr ₹147.95 Cr ₹126.28 Cr ₹121.89 Cr
Cash & Equivalents ₹54.78 Cr ₹39.48 Cr ₹62.62 Cr ₹68.83 Cr
Equity (Net Worth) ₹1,524.56 Cr ₹1,334.64 Cr ₹1,099.27 Cr ₹990.71 Cr
Equity Share Capital ₹41.47 Cr ₹10.36 Cr ₹10.25 Cr ₹10.24 Cr
Borrowings (Non-current) ₹0 ₹5.27 Cr ₹0 ₹28.61 Cr
Borrowings (Current) ₹18.73 Cr ₹8.92 Cr ₹0 ₹50.44 Cr
Total Debt (computed) ₹18.73 Cr ₹14.19 Cr ₹0 ₹79.05 Cr
Current Liabilities ₹334.02 Cr ₹294.33 Cr ₹245.87 Cr ₹264.97 Cr
Total Liabilities ₹613.5 Cr ₹532.7 Cr ₹455.79 Cr ₹510.9 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹350.7 Cr ₹262.75 Cr ₹264.07 Cr ₹247.09 Cr ₹253.27 Cr
Investing Cash Flow -₹223.13 Cr -₹201.06 Cr -₹89.41 Cr ₹46.79 Cr -₹735.05 Cr
Financing Cash Flow -₹115.29 Cr -₹86.63 Cr -₹181.2 Cr -₹292.33 Cr ₹162.52 Cr
Capital Expenditure ₹43.49 Cr ₹43.41 Cr ₹63.76 Cr ₹52.63 Cr ₹30.66 Cr
Free Cash Flow (computed) ₹307.21 Cr ₹219.34 Cr ₹200.31 Cr ₹194.46 Cr ₹222.61 Cr
Dividends Paid ₹20.73 Cr ₹18.46 Cr ₹20.5 Cr ₹40.97 Cr ₹40.94 Cr
Net Change in Cash ₹15.31 Cr -₹23.96 Cr -₹6.21 Cr ₹2.85 Cr -₹320.61 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹424.68 Cr ₹405.91 Cr ₹429.19 Cr ₹386.06 Cr ₹345.29 Cr ₹322.77 Cr ₹349.79 Cr ₹313.36 Cr ₹331 Cr ₹291.12 Cr ₹308.5 Cr ₹277.09 Cr
Other Income ₹8.16 Cr ₹9.02 Cr ₹89.1 Lakh ₹7.52 Cr ₹6.97 Cr ₹2.56 Cr ₹3.13 Cr ₹2.46 Cr ₹2.54 Cr ₹2.31 Cr ₹1.22 Cr ₹3.05 Cr
Total Income ₹432.84 Cr ₹414.93 Cr ₹430.08 Cr ₹393.58 Cr ₹352.26 Cr ₹325.32 Cr ₹352.92 Cr ₹315.81 Cr ₹333.54 Cr ₹293.42 Cr ₹309.72 Cr ₹280.14 Cr
Cost of Materials Consumed ₹78.48 Cr ₹79.24 Cr ₹87.75 Cr ₹79.05 Cr ₹71.53 Cr ₹64.55 Cr ₹69.46 Cr ₹63.15 Cr ₹67.09 Cr ₹57.25 Cr ₹61.27 Cr ₹56.96 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Employee Benefit Expense ₹95.47 Cr ₹94.22 Cr ₹95.39 Cr ₹92.28 Cr ₹82.19 Cr ₹81.43 Cr ₹78.44 Cr ₹71.69 Cr ₹71.47 Cr ₹69.51 Cr ₹69.75 Cr ₹65.06 Cr
Finance Costs ₹7.93 Cr ₹5.73 Cr ₹5.68 Cr ₹5.2 Cr ₹4.6 Cr ₹4.53 Cr ₹4.79 Cr ₹4.65 Cr ₹5.57 Cr ₹5.31 Cr ₹5.68 Cr ₹5.98 Cr
Depreciation & Amortisation ₹38.59 Cr ₹31.88 Cr ₹32.41 Cr ₹30.85 Cr ₹28.62 Cr ₹27.7 Cr ₹26.82 Cr ₹25.54 Cr ₹26.42 Cr ₹24.99 Cr ₹22.24 Cr ₹20.82 Cr
Other Expenses ₹142.71 Cr ₹137.6 Cr ₹137.83 Cr ₹124.98 Cr ₹129.27 Cr ₹104.78 Cr ₹112.02 Cr ₹99.7 Cr ₹112.46 Cr ₹99.52 Cr ₹102.67 Cr ₹92.13 Cr
Total Expenses ₹363.19 Cr ₹348.67 Cr ₹359.06 Cr ₹332.35 Cr ₹316.22 Cr ₹282.99 Cr ₹291.52 Cr ₹264.74 Cr ₹283.01 Cr ₹256.57 Cr ₹261.61 Cr ₹240.95 Cr
Profit Before Exceptional Items & Tax ₹69.66 Cr ₹66.25 Cr ₹71.03 Cr ₹61.23 Cr ₹36.04 Cr ₹42.34 Cr ₹61.4 Cr ₹51.08 Cr ₹50.53 Cr ₹36.85 Cr ₹48.11 Cr ₹39.19 Cr
Exceptional Items ₹10.69 Lakh -₹9.1 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹69.76 Cr ₹57.16 Cr ₹71.03 Cr ₹61.23 Cr ₹36.04 Cr ₹42.34 Cr ₹61.4 Cr ₹51.08 Cr ₹50.53 Cr ₹36.85 Cr ₹48.11 Cr ₹39.19 Cr
Total Tax Expense ₹18.8 Cr ₹15.07 Cr ₹18.14 Cr ₹15.99 Cr ₹6.81 Cr ₹10.86 Cr ₹14.7 Cr ₹12.97 Cr ₹14.01 Cr ₹9.57 Cr ₹12.45 Cr ₹10.21 Cr
Net Profit ₹50.96 Cr ₹42.09 Cr ₹52.89 Cr ₹45.25 Cr ₹29.23 Cr ₹31.47 Cr ₹46.7 Cr ₹38.11 Cr ₹36.53 Cr ₹27.29 Cr ₹35.66 Cr ₹28.98 Cr
  attributable to Owners ₹50.9 Cr ₹41.39 Cr ₹52.67 Cr ₹45.06 Cr ₹29.14 Cr ₹31.36 Cr ₹46.52 Cr ₹37.95 Cr ₹36.41 Cr ₹27.16 Cr ₹35.45 Cr ₹28.8 Cr
  attributable to NCI ₹5.65 Lakh ₹70.15 Lakh ₹22.2 Lakh ₹18.46 Lakh ₹8.96 Lakh ₹11.41 Lakh ₹17.89 Lakh ₹16.3 Lakh ₹11.91 Lakh ₹13.07 Lakh ₹20.51 Lakh ₹18.45 Lakh
Other Comprehensive Income ₹3.35 Cr ₹1.65 Cr ₹2 Cr -₹2.18 Cr ₹1.04 Cr -₹1.75 Cr -₹65.54 Lakh ₹1.05 Cr ₹5.94 Cr -₹40.43 Lakh -₹4.07 Cr -₹2.29 Cr
Total Comprehensive Income ₹54.31 Cr ₹43.74 Cr ₹54.89 Cr ₹43.07 Cr ₹30.28 Cr ₹29.72 Cr ₹46.04 Cr ₹39.16 Cr ₹42.47 Cr ₹26.88 Cr ₹31.59 Cr ₹26.69 Cr
EBITDA (computed) ₹116.18 Cr ₹103.86 Cr ₹109.12 Cr ₹97.27 Cr ₹69.27 Cr ₹74.56 Cr ₹93.01 Cr ₹81.27 Cr ₹82.52 Cr ₹67.15 Cr ₹76.03 Cr ₹65.99 Cr
Basic EPS ₹2.46 ₹7.99 ₹10.17 ₹8.70 ₹5.69 ₹6.11 ₹9.08 ₹7.41 ₹7.11 ₹5.30 ₹6.92 ₹5.62
Diluted EPS ₹2.46 ₹7.94 ₹10.13 ₹8.66 ₹5.66 ₹6.09 ₹9.03 ₹7.37 ₹7.08 ₹5.28 ₹6.90 ₹5.61
Latest 12 quarters shown of 25 on record.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2020
Revenue from Operations ₹1,365.47 Cr ₹1,216.54 Cr ₹1,103.43 Cr ₹1,066.04 Cr ₹936.29 Cr ₹665.31 Cr
Other Income ₹16.33 Cr ₹17.05 Cr ₹12 Cr ₹21.28 Cr ₹52.51 Cr ₹29.32 Cr
Total Income ₹1,381.8 Cr ₹1,233.59 Cr ₹1,115.42 Cr ₹1,087.32 Cr ₹988.8 Cr ₹694.63 Cr
Cost of Materials Consumed ₹252.72 Cr ₹244.49 Cr ₹220.48 Cr ₹235.55 Cr ₹217.72 Cr ₹167.25 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Employee Benefit Expense ₹297.44 Cr ₹271.98 Cr ₹246.6 Cr ₹228.16 Cr ₹176.74 Cr ₹147.67 Cr
Finance Costs ₹19.19 Cr ₹18.26 Cr ₹22.34 Cr ₹26.69 Cr ₹16.88 Cr ₹6.56 Cr
Depreciation & Amortisation ₹116.17 Cr ₹104.89 Cr ₹90.73 Cr ₹84.96 Cr ₹45.79 Cr ₹30.85 Cr
Other Expenses ₹477.09 Cr ₹431.95 Cr ₹377.87 Cr ₹333.02 Cr ₹300.05 Cr ₹177.79 Cr
Total Expenses ₹1,162.6 Cr ₹1,071.57 Cr ₹958.01 Cr ₹908.38 Cr ₹757.17 Cr ₹530.11 Cr
Profit Before Exceptional Items & Tax ₹219.2 Cr ₹162.02 Cr ₹157.41 Cr ₹178.95 Cr ₹231.63 Cr ₹164.52 Cr
Exceptional Items -₹7.96 Cr ₹0 ₹0 ₹0 ₹15.9 Cr -₹24.53 Cr
Profit Before Tax ₹211.24 Cr ₹162.02 Cr ₹157.41 Cr ₹178.95 Cr ₹247.53 Cr ₹139.99 Cr
Total Tax Expense ₹54.1 Cr ₹37.23 Cr ₹41.52 Cr ₹40 Cr ₹55.57 Cr ₹27.94 Cr
Net Profit ₹157.48 Cr ₹124.8 Cr ₹115.89 Cr ₹138.95 Cr ₹191.96 Cr ₹112.05 Cr
Other Comprehensive Income -₹17.53 Lakh -₹1.68 Cr -₹1.65 Cr -₹1.64 Cr -₹86.72 Lakh -₹1.51 Cr
Total Comprehensive Income ₹157.31 Cr ₹123.12 Cr ₹114.24 Cr ₹137.31 Cr ₹191.09 Cr ₹110.55 Cr
EBITDA (computed) ₹354.55 Cr ₹285.17 Cr ₹270.48 Cr ₹290.59 Cr ₹294.29 Cr ₹201.92 Cr
Basic EPS ₹7.60 ₹24.35 ₹22.63 ₹27.14 ₹37.52 ₹22.32
Diluted EPS ₹7.60 ₹24.24 ₹22.55 ₹27.05 ₹37.34 ₹22.22
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹1,870.48 Cr ₹1,684.9 Cr ₹1,472.7 Cr ₹1,434.29 Cr
Non-current Assets ₹1,524.27 Cr ₹1,428.78 Cr ₹1,200.26 Cr ₹1,168.86 Cr
Current Assets ₹346.19 Cr ₹256.12 Cr ₹272.44 Cr ₹265.44 Cr
Property, Plant & Equipment ₹174.8 Cr ₹168.69 Cr ₹142.15 Cr ₹125.84 Cr
Inventories ₹32.21 Cr ₹31.55 Cr ₹33.89 Cr ₹41.27 Cr
Trade Receivables ₹118.87 Cr ₹113.67 Cr ₹130.03 Cr ₹126.19 Cr
Cash & Equivalents ₹20.06 Cr ₹22.68 Cr ₹28.59 Cr ₹24.09 Cr
Equity (Net Worth) ₹1,389.11 Cr ₹1,244.45 Cr ₹1,031.19 Cr ₹936.02 Cr
Equity Share Capital ₹41.47 Cr ₹10.36 Cr ₹10.25 Cr ₹10.24 Cr
Borrowings (Non-current) ₹0 ₹0 ₹0 ₹30.77 Cr
Borrowings (Current) ₹0 ₹0 ₹0 ₹51.52 Cr
Total Debt (computed) ₹0 ₹0 ₹0 ₹82.29 Cr
Current Liabilities ₹265.41 Cr ₹245.08 Cr ₹234.37 Cr ₹253.27 Cr
Total Liabilities ₹481.37 Cr ₹440.46 Cr ₹441.51 Cr ₹498.28 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹317.89 Cr ₹275.01 Cr ₹269.01 Cr ₹237.74 Cr ₹187.95 Cr
Investing Cash Flow -₹209.05 Cr -₹196.09 Cr -₹81 Cr ₹46.72 Cr -₹675.54 Cr
Financing Cash Flow -₹111.18 Cr -₹84.5 Cr -₹183 Cr -₹287.87 Cr ₹181.2 Cr
Capital Expenditure ₹0 ₹38.53 Cr ₹32.76 Cr ₹48.55 Cr ₹33.63 Cr
Free Cash Flow (computed) ₹317.89 Cr ₹236.47 Cr ₹236.25 Cr ₹189.19 Cr ₹154.32 Cr
Dividends Paid ₹20.73 Cr ₹0 ₹20.5 Cr ₹40.97 Cr ₹40.94 Cr
Net Change in Cash -₹2.62 Cr -₹5.9 Cr ₹4.5 Cr -₹3.4 Cr -₹306.39 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹352.03 Cr ₹334.78 Cr ₹355.71 Cr ₹323.63 Cr ₹311.95 Cr ₹296.88 Cr ₹321.57 Cr ₹286.14 Cr ₹292.27 Cr ₹269.41 Cr ₹285.46 Cr ₹256.29 Cr
Other Income ₹8.82 Cr ₹2.22 Cr ₹2.52 Cr ₹2.78 Cr ₹7.6 Cr ₹3.03 Cr ₹3.59 Cr ₹2.83 Cr ₹2.02 Cr ₹5.19 Cr ₹2.01 Cr ₹2.78 Cr
Total Income ₹360.85 Cr ₹337 Cr ₹358.23 Cr ₹326.41 Cr ₹319.55 Cr ₹299.91 Cr ₹325.16 Cr ₹288.96 Cr ₹294.29 Cr ₹274.6 Cr ₹287.46 Cr ₹259.07 Cr
Cost of Materials Consumed ₹60.82 Cr ₹62.33 Cr ₹68.21 Cr ₹61.36 Cr ₹64.13 Cr ₹58.63 Cr ₹63.56 Cr ₹58.16 Cr ₹59.27 Cr ₹52.13 Cr ₹56.29 Cr ₹52.79 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Employee Benefit Expense ₹74.93 Cr ₹74.91 Cr ₹75.46 Cr ₹72.33 Cr ₹68.69 Cr ₹69.72 Cr ₹69.48 Cr ₹64.09 Cr ₹61.13 Cr ₹62.96 Cr ₹64.03 Cr ₹58.47 Cr
Finance Costs ₹6.56 Cr ₹4.37 Cr ₹3.97 Cr ₹4.29 Cr ₹4.43 Cr ₹4.49 Cr ₹4.73 Cr ₹4.61 Cr ₹5.65 Cr ₹5.24 Cr ₹5.62 Cr ₹5.83 Cr
Depreciation & Amortisation ₹32.8 Cr ₹27.72 Cr ₹27.79 Cr ₹27.86 Cr ₹27.28 Cr ₹26.85 Cr ₹26.01 Cr ₹24.76 Cr ₹25.24 Cr ₹24.14 Cr ₹21.37 Cr ₹19.99 Cr
Other Expenses ₹126.13 Cr ₹117.39 Cr ₹120.69 Cr ₹112.88 Cr ₹126.38 Cr ₹103.43 Cr ₹106.51 Cr ₹95.62 Cr ₹97.95 Cr ₹95.49 Cr ₹97.66 Cr ₹86.77 Cr
Total Expenses ₹301.24 Cr ₹286.72 Cr ₹296.11 Cr ₹278.73 Cr ₹290.91 Cr ₹263.11 Cr ₹270.3 Cr ₹247.24 Cr ₹249.23 Cr ₹239.97 Cr ₹244.97 Cr ₹223.84 Cr
Profit Before Exceptional Items & Tax ₹59.61 Cr ₹50.28 Cr ₹62.12 Cr ₹47.68 Cr ₹28.64 Cr ₹36.8 Cr ₹54.87 Cr ₹41.72 Cr ₹45.05 Cr ₹34.63 Cr ₹42.49 Cr ₹35.23 Cr
Exceptional Items ₹0 -₹7.96 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹59.61 Cr ₹42.32 Cr ₹62.12 Cr ₹47.68 Cr ₹28.64 Cr ₹36.8 Cr ₹54.87 Cr ₹41.72 Cr ₹45.05 Cr ₹34.63 Cr ₹42.49 Cr ₹35.23 Cr
Total Tax Expense ₹16.35 Cr ₹10.29 Cr ₹15.49 Cr ₹12.1 Cr ₹4.78 Cr ₹9.4 Cr ₹12.6 Cr ₹10.44 Cr ₹13.27 Cr ₹7.93 Cr ₹11.21 Cr ₹9.1 Cr
Net Profit ₹43.24 Cr ₹32.03 Cr ₹46.63 Cr ₹35.58 Cr ₹23.85 Cr ₹27.4 Cr ₹42.26 Cr ₹31.28 Cr ₹31.78 Cr ₹26.7 Cr ₹31.28 Cr ₹26.13 Cr
Other Comprehensive Income ₹44.06 Lakh ₹2.18 Cr -₹2.38 Cr -₹41.97 Lakh ₹89.52 Lakh -₹72.06 Lakh -₹1.44 Cr -₹41.24 Lakh ₹51.66 Lakh -₹72.2 Lakh -₹1.03 Cr -₹40.93 Lakh
Total Comprehensive Income ₹43.68 Cr ₹34.21 Cr ₹44.26 Cr ₹35.16 Cr ₹24.75 Cr ₹26.68 Cr ₹40.82 Cr ₹30.87 Cr ₹32.3 Cr ₹25.98 Cr ₹30.24 Cr ₹25.72 Cr
EBITDA (computed) ₹98.97 Cr ₹82.37 Cr ₹93.87 Cr ₹79.84 Cr ₹60.34 Cr ₹68.13 Cr ₹85.61 Cr ₹71.09 Cr ₹75.94 Cr ₹64.01 Cr ₹69.48 Cr ₹61.04 Cr
Basic EPS ₹2.09 ₹6.18 ₹9.00 ₹6.87 ₹4.65 ₹5.35 ₹8.24 ₹6.11 ₹6.21 ₹5.21 ₹6.11 ₹5.10
Diluted EPS ₹2.09 ₹6.15 ₹8.97 ₹6.84 ₹4.63 ₹5.32 ₹8.21 ₹6.07 ₹6.18 ₹5.19 ₹6.09 ₹5.09
Latest 12 quarters shown of 25 on record.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Metropolis Healthcare Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Metropolis Healthcare Limited

As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 48.87%, foreign institutional investors hold 10.43%, domestic institutional investors hold 35.79%, retail and other public shareholders hold 4.91% of Metropolis Healthcare Limited. The company had 49,175 shareholders on record.

Promoters: 48.87%DII (Domestic Institutional): 35.79%FII (Foreign Institutional): 10.43%Retail & Others: 4.91%
Mar 2026
QUARTER
48.87% Promoters
35.79% DII (Domestic Institutional)
10.43% FII (Foreign Institutional)
4.91% Retail & Others
Promoter holding - history
Now 48.87% · Mar 2026High 57.41% · Apr 2019Low 48.87% · Mar 2026
47%50%53%56%59%Apr 2019Dec 2020Sep 2022Jun 2024Mar 2026Apr 2019: 57.41%Jun 2019: 57.41%Sep 2019: 57.41%Dec 2019: 57.41%Mar 2020: 56.90%Jun 2020: 50.81%Sep 2020: 50.57%Dec 2020: 50.39%Mar 2021: 50.38%Jun 2021: 50.37%Sep 2021: 50.33%Dec 2021: 49.50%Mar 2022: 49.79%Jun 2022: 49.79%Sep 2022: 49.76%Dec 2022: 49.76%Mar 2023: 49.75%Jun 2023: 49.75%Sep 2023: 49.74%Dec 2023: 49.74%Mar 2024: 49.67%Jun 2024: 49.62%Sep 2024: 49.43%Dec 2024: 49.40%Mar 2025: 48.90%Jun 2025: 48.89%Sep 2025: 48.89%Dec 2025: 48.88%Mar 2026: 48.87%57.41%48.87%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters48.87%48.88%48.89%48.89%48.90%49.40%
Public51.13%51.12%51.11%51.11%51.10%50.60%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Promoters48.87%48.90%49.67%49.75%49.79%50.38%56.90%
Public51.13%51.10%50.33%50.25%50.21%49.62%43.10%
Promoter change (YoY, %pts)-0.03-0.77-0.08-0.04-0.59-6.52-

Board & Governance of Metropolis Healthcare Limited

As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Metropolis Healthcare Limited has 10 directors - 5 independent and 2 executive. The board is chaired by Ameera Shah.

DirectorPositionOn board sinceListed boards
Sushil Kanubhai Shah Non-Executive - Non Independent Director 2005-08-17 1
Ameera Shah Executive Director · Chairperson 2008-05-06 2
Surendran Chemmenkotil Executive Director · MD 2025-06-01 1
Hemant Sachdev Non-Executive - Non Independent Director 2021-05-27 2
Aparna Chetan Rajadhyaksha Non-Executive - Non Independent Director 2024-05-22 1
Sanjay Bhatnagar Non-Executive - Independent Director 2018-09-07 2
Vivek Gambhir Non-Executive - Independent Director 2018-09-07 2
Subramanian Ranganathan Non-Executive - Independent Director 2023-08-21 3
Purvi Sheth Non-Executive - Independent Director 2025-03-17 5
Rehan Khan Non-Executive - Independent Director 2025-05-13 1
Board Committees
CommitteeMembers
Audit Committee Subramanian Ranganathan (Chairperson), Vivek Gambhir, Sanjay Bhatnagar, Rehan Khan
Nomination and remuneration committee Purvi Sheth (Chairperson), Vivek Gambhir, Sanjay Bhatnagar
Stakeholders Relationship Committee Vivek Gambhir (Chairperson), Ameera Shah, Sushil Kanubhai Shah
Risk Management Committee Ameera Shah (Chairperson), Surendran Chemmenkotil, Subramanian Ranganathan
Corporate Social Responsibility Committee Purvi Sheth (Chairperson), Ameera Shah, Subramanian Ranganathan, Rehan Khan

Group Structure of Metropolis Healthcare Limited

Metropolis Healthcare Limited has 4 subsidiary companies. This group structure data is as of FY 2023. The corporate group structure reflects Metropolis Healthcare Limited's business expansion strategy and organizational complexity.

4
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Amin's Pathology Laboratory Private Limited U52300MH2012PTC236779 -
Centralab Healthcare Services Private Limited U85110KA2011PTC057920 -
Metropolis Histoxpert Digital Services Private Limited U85320MH2018PTC304941 -
Ekopath Metropolis Lab Services Private Limited U93000MH2013PTC240481 -

Showing major subsidiaries. Total: 4.

Charges & Borrowings of Metropolis Healthcare Limited

Open charges
₹60.19 Cr
Satisfied charges
₹416.05 Cr
Breakdown by lending institutions
Others₹30.00 Cr
Hdfc Bank Limited₹30.00 Cr
Icici Bank Limited₹0.12 Cr
Textile Trafers Co-Op. Bank₹0.07 Cr
Latest charge details
DateLenderAmountStatus
19 Jun 2025 Others ₹30 Cr Open
09 Jun 2008 Hdfc Bank Limited ₹30 Cr Open
31 May 2007 Icici Bank Limited ₹11.65 Lakh Open
03 Nov 1997 Textile Trafers Co-Op. Bank ₹7 Lakh Open
07 Apr 2022 Hdfc Bank Limited ₹150 Cr Satisfied

Total charge records: 17 View all charges

Employees and EPFO Compliance at Metropolis Healthcare Limited

Metropolis Healthcare Limited has a workforce of 4,503 employees as of Apr 04, 2024.

Employee count
4,503
Active EPFO establishments
6
Employee growth
14.9%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Metropolis Healthcare Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Metropolis Healthcare Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Metropolis Healthcare Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Metropolis Healthcare Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Metropolis Healthcare Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Metropolis Healthcare Limited

MSME Payment Delays by Metropolis Healthcare Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Metropolis Healthcare Limited

Subsidiaries & Group Companies of Metropolis Healthcare Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Metropolis Healthcare Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Metropolis Healthcare Limited

MCA Filings & Documents of Metropolis Healthcare Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Metropolis Healthcare Limited

Activity
13 Aug 2025
Metropolis Healthcare Limited last Annual general meeting of members was held on 13 Aug 2025 as per latest MCA records.
Charges
19 Jun 2025
A charge with Others amounted to Rs. 30.00 Cr with Charge ID 101122027 was registered on 19 Jun 2025.
Directors
01 Jun 2025
Chemmenkotil Surendran was appointed as a Managing Director on 01 Jun 2025 & has been associated with this company since 1 year 1 month.
Directors
13 May 2025
Rehan Khan Abbas was appointed as a Director on 13 May 2025 & has been associated with this company since 1 year 2 months.
Activity
31 Mar 2025
Metropolis Healthcare Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Directors
17 Mar 2025
Purvi Sheth was appointed as a Director on 17 Mar 2025 & has been associated with this company since 1 year 3 months.

Recent News on Metropolis Healthcare Limited

Frequently Asked Questions about Metropolis Healthcare Limited

Metropolis Healthcare Limited is an active public limited company in the healthcare sector based in Mumbai, Maharashtra, India. It was incorporated on 10 November 2000 (26+ years old) and is registered under CIN L73100MH2000PLC192798. Listed on BSE: 542650 and NSE: METROPOLIS. The company has 4,503 employees.

Metropolis Healthcare Limited reported revenue of ₹1,346.32 Cr for FY 2025 (up 11.00% YoY).

The current directors of Metropolis Healthcare Limited are:

The primary industry of Metropolis Healthcare Limited is healthcare. The company specifically operates in diagnostic centers and pathology labs. The company is currently active in this sector.

Yes. Metropolis Healthcare Limited is listed on both BSE (code: 542650) and NSE (symbol: METROPOLIS).

Metropolis Healthcare Limited can be reached at the registered office: 4Th Floor East Wing Plot – 254 B, Nirlon House Dr. Annie Besant Road Worli, Mumbai, Maharashtra, India – 400030, or through the website metropolisindia.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available